[1]张寒 王洪海 徐荣林.参苓白术散合龟鹿二仙汤加减对原发性骨质疏松症脾肾两虚证患者骨代谢及炎症反应的影响[J].国际中医中药杂志,2021,43(12):1204-1208.[doi:10.3760/cma.j.cn115398-202 10728-00245]
 Zhang Han,Wang Honghai,Xu Ronglin.Effects of Shenling-Baizhu Powder combined with modified Guilu-Erxian Decoction on bone metabolism and inflammation response in osteoporosis patients[J].,2021,43(12):1204-1208.[doi:10.3760/cma.j.cn115398-202 10728-00245]
点击复制

参苓白术散合龟鹿二仙汤加减对原发性骨质疏松症脾肾两虚证患者骨代谢及炎症反应的影响

参考文献/References:

[1].祝晓雨,张伟光,赵志刚. 骨质疏松症国内外药物治疗的研究现状[J]. 中国临床药理学杂志,2020,36(5):588-592. DOI :10.13699/j.cnki.1001-6821.2020.05.030.
[2].Narla RR,Hirano LA,Lo S,et al. Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures[J]. J Investig Med, 2019 ,67(4):743-749. DOI:10.1136/jim-2018-000907
[3].李娜,杜丽坤,王冰梅. 原发性骨质疏松症的中医证素辨证法[J]. 中国骨质疏松杂志,2019,25(7):1010-1014. DOI:10. 3969/j.issn.1006-7108.2019.07.026.
[4].明章书,吴小华,王巧,等. 加味龟鹿二仙汤对原发性卵巢功能不全小鼠卵巢miR-190表达的影响[J]. 中华中医药杂志,2019,34(11):5410-5414.
[5].章振林,金小岚,夏维波. 原发性骨质疏松症诊疗指南(2017版)要点解读[J]. 中华骨质疏松和骨矿盐疾病杂志,2017, 10(5):411-412. DOI:10.3969/j.issn.1674-2591.2017.05.001.
[6].郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002:67-68.
[7].李绍烁,顾一丹,尹恒,等. 基于网络药理学方法分析“龟板-鹿角”药对活性成分治疗骨质疏松症的分子机制[J]. 中国组织工程研究,2020,24(35):5668-5674. DOI:10.3969/j.issn. 2095-4344.2925.

相似文献/References:

[1]康轶鑫 王道全 卢岩 张晶.益肾补骨推拿法治疗骨质疏松症的实验方法探讨[J].国际中医中药杂志,2011,33(12):1086.[doi:10.3760/cma.j.issn.1673-4246.2011.12.012]
 KANG Yi-xin*,WANG Dao-quan,LU Yan,et al.Experimental research of treating osteoporosis with the method of kidney-tonifying and bone-strengthening massage therapy[J].,2011,33(12):1086.[doi:10.3760/cma.j.issn.1673-4246.2011.12.012]
[2]杨芳 郑洪新.从“骨肉不相亲”谈骨质疏松症的形成[J].国际中医中药杂志,2012,34(03):232.[doi:10.3760/cma.j.issn.1673-4246.2012.03.013]
 YANG Fang,ZHENG Hong-xin.Approach the formation of osteoporosis by the theory of “disharmony between bone and muscle”[J].,2012,34(12):232.[doi:10.3760/cma.j.issn.1673-4246.2012.03.013]
[3]张永良 沈影超 王强 周波凯 顾云峰.社区-综合医院“治未病”互动管理模式对农村老年人骨质疏松自我康复的影响[J].国际中医中药杂志,2012,34(07):598.[doi:10.3760/cma.j.issn.1673-4246.2012.07.007]
 ZHANG Yong-liang,SHEN Ying-chao*,WANG Qiang,et al.Effect of the community-general hospital interactive management mode of preventive treatment on osteoporosis self-rehabilitation of rural elderly residents[J].,2012,34(12):598.[doi:10.3760/cma.j.issn.1673-4246.2012.07.007]
[4]王广伟 黄宏兴 霍力为 付丰平 李泽钿.绝经后骨质疏松症患者脂肪含量与骨密度的相关性研究[J].国际中医中药杂志,2012,34(09):782.[doi:10.3760/cma.j.issn.1673-4246.2012.09.005]
 WANG Guang-wei*,HUANG Hong-xing,HUO Li-wei,et al.Study of the correlation between fat content of postmenopausal osteoporosis patients and bone mineral density[J].,2012,34(12):782.[doi:10.3760/cma.j.issn.1673-4246.2012.09.005]
[5]康轶鑫 张广元 于有建.单味解表药治疗骨质疏松症的研究进展[J].国际中医中药杂志,2010,32(02):180.[doi:10.3760/cma.j.issn.1673-4246.2010.02.047]
 KANG Yi-xin,ZHANG Guang-yuan,YU You-jian..Research progress of single Chinese exterior-relieving medicine in the treatment of osteoporosis[J].,2010,32(12):180.[doi:10.3760/cma.j.issn.1673-4246.2010.02.047]
[6]郑在根 郑洪新.韩国治疗骨质疏松症中药研究概况[J].国际中医中药杂志,2014,36(02):97.[doi:10.3760/cma.j.issn.1673-4246.2014.02.001]
 Jung Jaekeun,Zheng Hongxin*.The situation of osteoporosis herbal medicines studies in South Korean journals[J].,2014,36(12):97.[doi:10.3760/cma.j.issn.1673-4246.2014.02.001]
[7]黄桂忠 李伟居 刘意兰.加味海七丸治疗老年性骨质疏松症临床研究[J].国际中医中药杂志,2014,36(06):513.[doi:10.3760/cma.j.issn.1673-4246.2014.06.010]
 Huang Guizhong,Li Weiju,Liu Yilan..Curative effect of Jiawei-Haiqi pill on senile osteoporosis[J].,2014,36(12):513.[doi:10.3760/cma.j.issn.1673-4246.2014.06.010]
[8]宋清扬 王小星 牛秀茹 李敏 王爽 孙佳.自拟健脾益肾方治疗老年骨骼肌减少症脾肾两虚、寒湿内蕴证临床研究[J].国际中医中药杂志,2020,42(08):733.[doi:10.3760/cma.j.cn115398-20191009-00033]
 Song Qingyang,Wang Xiaoxing,Niu Xiuru,et al.Clinical research of Jianpi-Yishen Decoction in treating sarcopenia aged patients with syndrome of spleen-kidney deficiency and cold-dampness[J].,2020,42(12):733.[doi:10.3760/cma.j.cn115398-20191009-00033]

备注/Memo

(收稿日期:2021-07-28)

更新日期/Last Update:

2021-12-16